健保碼 | 新價 | 藥品名稱 | 製藥廠 |
AC59782100 | 6.3 | VIDATIN TAB. 50MG | 生達化學製藥股份有限公司二廠 |
AC615254FK | 132 | FLUTIMY NASAL SPRAY 27.5 MCG/SPRAY | 健喬信元醫藥生技股份有限公司健喬廠 |
AC61906100 | 6.7 | UNISIA 8MG/5MG TABLETS | 益邦製藥股份有限公司 |
BA25104100 | 107 | Alendronate Sandoz 70mg Tablets | Novartis Pharmaceutical Manufacturing LLC |
BC248774FK | 166 | Avamys Nasal Spray | GLAXO WELLCOME, S.A. |
BC25033161 | 1355 | Spiriva Respimat 2.5mcg, Solution for Inhalation | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
BC25282443 | 718 | Onbrez Breezhaler 150 mcg inhalation powder, hard capsule | Siegfried Barbera S.L. |
BC25306100 | 6.7 | GALVUS TABLETS 50MG | Novartis Pharmaceutical Manufacturing LLC |
BC25458100 | 35.8 | Pradaxa Capsules 150 mg | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
BC25459100 | 35.8 | Pradaxa Capsules 110 mg | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
BC25480100 | 6.7 | Galvus Met 50/500 film-coated tablets | NOVARTIS PHARMA PRODUKTIONS GMBH |
BC25481100 | 6.7 | Galvus Met 50/850 film-coated tablets | NOVARTIS PHARMA PRODUKTIONS GMBH |
BC25482100 | 6.7 | Galvus Met 50/1000 film-coated tablets | NOVARTIS PHARMA PRODUKTIONS GMBH |
BC25691100 | 24.2 | BRILINTA Film-coated Tablets 90 mg | ASTRAZENECA AB |
BC26216100 | 19.5 | Betmiga Prolonged-release Tablets 50mg | AVARA PHARMACEUTICAL TECHNOLOGIES, INC. |
BC26217100 | 19.5 | Betmiga Prolonged-release Tablets 25mg | AVARA PHARMACEUTICAL TECHNOLOGIES, INC. |
BC26406100 | 26.6 | Jardiance 10mg Film-Coated Tablets | ROTTENDORF PHARMA GMBH |
BC26475100 | 15.6 | Forxiga Film-coated Tablets 5mg | AstraZeneca Pharmaceuticals LP |
BC26476100 | 25.4 | Forxiga Film-coated Tablets 10mg | AstraZeneca Pharmaceuticals LP |
BC27801100 | 1446 | Talzenna Capsules 0.25 mg | EXCELLA GMBH & CO. KG |
BC27825414 | 444 | Vyzulta 0.024%, solution | BAUSCH & LOMB INCORPORATED |
BC27825421 | 877 | Vyzulta 0.024%, solution | BAUSCH & LOMB INCORPORATED |
BC28366100 | 4440 | XPOVIO [SELINEXOR] 20 MG FILM-COATED TABLETS | CATALENT CTS, LLC |
KC00807219 | 5675 | AVASTIN INJECTION | F. HOFFMANN-LA ROCHE LTD. |
KC00911206 | 18395 | SIMPONI TM [GOLIMUMAB],SOLUTION FOR INJECTION | CILAG AG. |
KC00911209 | 18395 | SIMPONI TM [GOLIMUMAB],SOLUTION FOR INJECTION | CILAG AG. |
KC00918209 | 4360 | Prolia | AMGEN MANUFACTURING,LIMITED |
KC01117219 | 5008 | MVASI Solution for Injection | Patheon Manufacturing Services LLC |
KC01129299 | 40.5 | Refixia powder and solvent for solution for injection 500 IU | NOVO NORDISK A/S |
KC01130299 | 40.5 | Refixia powder and solvent for solution for injection 1000 IU | NOVO NORDISK A/S |
KC01131299 | 40.5 | Refixia powder and solvent for solution for injection 2000 IU | NOVO NORDISK A/S |
KC01185219 | 5008 | ALYMSYS CONCENTRATE FOR SOLUTION FOR INFUSION | Universal Farma, S.L. (CHEMO) |
KC01245219 | 5008 | VEGZELMA CONCENTRATE FOR SOLUTION FOR INFUSION | CELLTRION INC. |
X000288248 | 25698 | NOVOSEVEN | Novo Nordisk A/S |
X000291209 | 3387 | HYPERRHO S/D FULL DOSE | Grifols Therapeutics Inc. |
X000292229 | 1492 | GANCICLOVIR INJECTION 500 MG PER 10ML | PHARMASCIENCE INC. |
X000342121 | 2154 | TOBLAIR 300MG/5ML NEBULISER SOLUTION | VEM ILAC SAN. VE TIC. A.S. |
X000345221 | 163 | 阿雷彼阿慶注射液 | 瑞士藥廠股份有限公司新市廠 |